Notice of Intent to Sole Source 2 sets of QX200 ddPCR Systems
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH - CC
Contract Value
Not provided
Codes & Classification
Solicitation Number
NOI-CC-26-000112
NAICS
325414 - Biological Product (except Diagnostic) Manufacturing
Classification Code
J066
Additional Details
Documents2
The National Institutes of Health (NIH), Clinical Center (CC), through its Office of Purchasing and Contracts, has issued a Special Notice indicating its intent to negotiate a sole source procurement with Bio-Rad Laboratories. This action is not a request for proposal but rather a notification of the agency’s plan to renew a five-year service contract for two sets of QX200 AutoDG droplet digital PCR (ddPCR) Systems, specifically supporting the Center for Cellular Engineering (CCE) in Bethesda, Maryland.
The scope of this procurement encompasses comprehensive service coverage for two QX200 AutoDG ddPCR Systems (serial numbers: 771BR3558/773BR1880 and 773BR2063/771BR4088) over a five-year period, structured as a base year plus four option years. The contract period is scheduled from January 23, 2026, through January 22, 2031. The total contract value is $151,494, with an annual service rate of $30,298.80.
These ddPCR systems are critical to the NIH Clinical Center’s mission, as they are utilized for vector copy number (VCN) detection in clinical cellular product lot release assays. Additionally, they support the development of new protocols for assessing gene modification efficiencies and quality control of cell selection methods. The uninterrupted maintenance and service of these instruments are essential to ensure the reliability and accuracy of patient care testing and ongoing research activities.
The procurement is classified under NAICS code 325414 (Biological Product [except Diagnostic] Manufacturing), with a Product Service Code of J066. There are no set-aside requirements associated with this notice, and the procurement is not restricted to any particular socioeconomic category.
The statutory authority for this sole source action is 41 U.S.C. 253(c)(1), as implemented by FAR 6.302-1, which permits other than full and open competition when only one responsible source is capable of fulfilling the agency’s requirements. The NIH has determined that Bio-Rad Laboratories is the only vendor able to provide the requisite service and maintenance for these specialized systems.
Interested parties who believe they can meet the government’s requirements are invited to submit a capability statement by email to [email protected], referencing NOI-CC-26-000112, no later than 12:00 am Eastern Standard Time on December 18, 2025. All responses received by the deadline will be considered; however, the final decision to compete this requirement remains at the sole discretion of the government.
The place of performance for this contract is Bethesda, Maryland, United States. The contracting entity is the National Institutes of Health – Clinical Center, a federal office. Additional details and attachments related to this notice can be accessed via the official SAM.gov opportunity posting (Opportunity ID: f104651ce53548bfb49fd50b8d039525).
This notice provides an opportunity for qualified vendors to express interest and demonstrate capability, but it is not a solicitation for competitive proposals. The continuity of service for these critical laboratory systems is paramount to the NIH Clinical Center’s patient care and research objectives.